Reuters Health News Summary

What you need to know about the coronavirus right now Here's what you need to know about the coronavirus right now: Florida passes New York Emergent signs $174 million deal to make AstraZeneca's potential COVID-19 vaccine Emergent BioSolutions Inc said on Monday it signed a $174 million agreement with AstraZeneca to develop and manufacture the British drugmaker's COVID-19 vaccine candidate.

Following is a summary of current health news briefs. How a U.S. Navy base in the Gulf tackles coronavirus

At the U.S. Navy's main base in the Gulf, military staff are strictly abiding by rules to stem the spread of the new coronavirus. The Bahrain base houses the U.S. Navy's Fifth Fleet and U.S. Naval Forces Central Command (USNAVCENT), operating in the Gulf amid high tensions between Iran and the United States. What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now: Florida passes New York Emergent signs $174 million deal to make AstraZeneca's potential COVID-19 vaccine

Emergent BioSolutions Inc said on Monday it signed a $174 million agreement with AstraZeneca to develop and manufacture the British drugmaker's COVID-19 vaccine candidate. AstraZeneca in June picked Emergent to help produce 300 million doses of its potential COVID-19 vaccine pledged to the United States. Hundreds jam airport as evacuations from Vietnam's Danang begin

The airport in the central Vietnamese tourism hotspot of Danang was packed on Monday after three residents tested positive for the coronavirus and the evacuation of 80,000 people began. The Southeast Asian country is back on high alert after authorities on Saturday confirmed the first community infections since April, and another three cases on Sunday, all in or around Danang. Second wave of coronavirus in Asia prompts fresh lockdowns

Countries around Asia are confronting a second wave of coronavirus infections and are clamping down again to try to contain the disease, with Australia recording a record daily rise in cases and Vietnam locking down the city of Danang. Mainland China is battling the most aggressive return of COVID-19 in months, confirming 57 new locally transmitted cases on Sunday, the highest level since early March, driven by fresh infections in the far western region of Xinjiang. The U.S. has more COVID-19 testing than most. So why is it falling so short?

The United States might have more COVID-19 testing capacity than any other country. So why have we seen laboratories overwhelmed and many patients again waiting a week or more for results? At the heart of the crisis is a reliance by public and private labs on automated testing equipment that locks them in to using proprietary chemical kits and other tools made by a handful of manufacturers. AstraZeneca bets up to $6 billion on new Daiichi cancer drug

AstraZeneca will pay up to $6 billion to Japan's Daiichi Sankyo under the drugmakers' second multi-billion dollar oncology collaboration to develop and market a new type of targeted cancer treatment. The British drugmaker has been bolstering its portfolio of cancer therapies, particularly ADCs, a major area of focus for the company as it also ploughs on with its coronavirus vaccine candidate. Moderna's COVID-19 vaccine candidate moves into late-stage trial

Moderna Inc said on Monday it has started a U.S. government-backed late-stage trial for its COVID-19 vaccine candidate, the first to be implemented under the Trump administration's Operation Warp Speed anti-coronavirus program. News of the study, which will test the response to the vaccine in 30,000 adults who do not have the respiratory illness, pushed shares in Cambridge, Massachusetts-based Moderna up 11% at $81.31 before the bell. WHO says travel bans cannot be indefinite; countries must fight virus

Bans on international travel cannot stay in place indefinitely, and countries are going to have to do more to reduce the spread of the novel coronavirus within their borders, the World Health Organization said on Monday. A surge of infections has prompted countries to reimpose some travel restrictions in recent days, with Britain throwing the reopening of Europe's tourism industry into disarray by ordering a quarantine on travellers returning from Spain. Explainer: Trump's plan to cut drug prices

U.S. President Donald Trump on Friday signed four executive orders designed to reduce drug costs for consumers, in a bid to highlight his commitment to cutting prescription prices ahead of the November presidential election. The orders, which range from relaxing drug importation rules to cutting Medicare payments to drugmakers, are far reaching but experts say they are unlikely to take effect in the near term and in some cases lack specifics.